Melinda Taschetta-Millane, Editorial Director
Melinda Taschetta-Millane, Editorial Director
Blog | Melinda Taschetta-Millane, Editorial Director | RSNA | October 30, 2019

See Possibilities Together

RSNA 2019 will delve into the possibilities of imaging by featuring an expanded artificial intelligence presence this yea

See Possibilities Together is the theme for the Radiological Society of North America’s (RSNA) 105th meeting and scientific assembly, and this year invites attendees to experience the hands-on, cutting-edge technology of artificial intelligence (AI), 3-D printing and virtual reality … and a whole lot more. The meeting will take place at Chicago’s McCormick Place Dec. 1-6, 2019.

RSNA 2019 will delve into the possibilities of imaging by featuring an expanded artificial intelligence presence this year. Debuting in a new, larger space on a lower level in the North Building, the showcase expansion allows RSNA to create a central hub of AI activities for RSNA attendees. “Many RSNA meeting attendees seek out AI subject matter,” said Steve Drew, RSNA assistant executive director of scientific assembly, informatics and corporate relations. “Creating an encompassing showcase on artificial intelligence for exhibitors, educators and researchers will create a dynamic environment for our attendees.”

Included in this AI destination area will be more than 100 companies focused on AI products and solutions, covering more than 40,000 sq. ft. of exhibit space. A larger open-air theater located in the center of the showcase will feature thirty-nine 20-minute vendor presentations on various AI topics throughout the week. The hands-on RSNA Deep Learning Classroom will offer 14 courses for practicing radiologists to help better understand the clinical relevance of AI. In addition, a new classroom will allow vendors to demonstrate their products in a hands-on environment, and a special exhibit will host a demonstration of emerging data technologies and the data standards that enable them.

Be sure to visit the ITN team in the South Hall, booth 3148. We will be featuring our various customizable comparison charts, as well the October and November/December issues of ITN, and much more. Our editorial team invites you to stop by the booth and chat with us about the new technologies that you are seeing at RSNA. We’d also like to hear more about your interests, goals and concerns as we head into a new year. As a reader-driven publication, it is our ultimate goal to provide you with the information you need to remain competitive and informed in the industry ... we want your feedback.

As we move into a new decade, the ITN team is looking forward to seeing many new possibilities together with you. We have some exciting plans in the works, including a major format change, and even more customizable electronic industry comparison charts — a free, ready-reference to assist with specifying, recommending and authorizing technology purchases.
We look forward to making new possibilities realities with you in 2020.

 

Related Content

A physician working in a coronavirus care center nearby Daegu, South Korea, is using Lunit INSIGHT CXR to interpret chest X-ray image of a coronavirus patient. Photo by Seoul National University Hospital

A physician working in a coronavirus care center nearby Daegu, South Korea, is using Lunit INSIGHT CXR to interpret chest X-ray image of a coronavirus patient. Photo by Seoul National University Hospital

News | Artificial Intelligence | March 30, 2020
March 30, 2020 — Lunit, a medical AI software company that dev
Phase III response to the COVID-19 public health emergency (PHE) CARES Act signed into law #CARESAct #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
Feature | Coronavirus (COVID-19) | March 28, 2020 | By Melinda Taschetta-Millane
On March 27, the House of Representatives approved a historic $2
CoronaCare is designed to help healthcare providers track COVID-19 (coronavirus) related symptoms of potentially infected patients. The platform enables communication with patients outside of facility walls and the ability to request the return of high-risk patients for more in-depth care. #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Coronavirus (COVID-19) | March 27, 2020
March 27, 2020 — PaxeraHealth has spent years building and be
AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis to improve the overall efficiency of the radiology department. It is being developed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19). #COVID19 #coronavirus #SARScov2

AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis to improve the overall efficiency of the radiology department. It is being developed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19).

Feature | Coronavirus (COVID-19) | March 27, 2020 | Jilian Liu, M.D., HIMSS Greater China
An older couple walked into the Hubei Provincial Hospital of Integrated Chinese and Western Medicine near their neigh
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Typical CT imaging features for COVID-19. Unenhanced, thin-section axial images of the lungs in a 52-year-old man with a positive RT-PCR (A-D) show bilateral, multifocal rounded (asterisks) and peripheral GGO (arrows) with superimposed interlobular septal thickening and visible intralobular lines (“crazy-paving”). Routine screening CT for diagnosis or exclusion of COVID-19 is currently not recommended by most professional organizations or the US Centers for Disease Control and Prevention. Image courtesy of RSNA

News | Coronavirus (COVID-19) | March 26, 2020
March 26, 2020 — The Radiological Society of North America (RSNA
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 #ACR20
News | Radiology Education | March 25, 2020
March 25, 2020 — The American College of Radiology (ACR) Annual Me
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Coronavirus (COVID-19) | March 25, 2020
March 25, 2020 — According to a statement on March 24 from Commissioner of Food and Drugs - Food and Drug Administrat